Data as of Oct 22
| +0.0099 / +1.24%|
The 1 analysts offering 12-month price forecasts for DelMar Pharmaceuticals Inc have a median target of 4.53, with a high estimate of 4.53 and a low estimate of 4.53. The median estimate represents a +459.33% increase from the last price of 0.81.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.